Low Testosterone Drug Lawsuits Contend Testosterone Manufacturers Failed To Warn That Their Testosterone Products Could Cause Stroke, Heart Attack, And Cardiac Death.

The federal litigation involving low testosterone drug lawsuits against AndroGel and Androderm, is rapidly growing and now numbers over 5,590 lawsuit claims. The testosterone treatment therapy complaints contend that manufacturers of Low T drugs, such as Axiron and Testim, failed to warn health care professionals and patients that their testosterone medications can cause heart attack, stroke, blood clots, and cardiac death in men who are prescribed the testosterone products.

The number of testosterone lawsuits has climbed to 5,594 claims as of April 19, according to the U.S. District Court, Northern District of Illinois case list. All federally filed testosterone therapy treatment lawsuits are consolidated in the Northern Illinois court as a way of streamlining the pretrial process. Consolidating cases with common allegations helps to prevent inconsistent pretrial rulings and avoids duplication of discovery. The industry-wide multidistrict litigation (MDL) for testosterone claims, regardless of the manufacturer named as a defendant, was established in June 2014. (In re: Testosterone Therapy Lawsuits Product Liability Litigation – MDL No. 2545)

Wright & Schulte LLC, a nationwide law firm, is representing men in testosterone complaints in this federal MDL. The firm offers free testosterone drug lawsuit evaluations to men, or their survivors, who believe they have suffered heart attacks, strokes, blood clots or death after using low testosterone therapy drugs such as AndroGel, Androderm or Testim. To speak with one of the law firm’s experienced attorneys, call 1-800-399-0795 or visit yourlegalhelp.com for more information on Low-T drug side-effects and other prescription drug information.

The move to consolidate the federally filed testosterone complaints came on the heels of an investigation by the U.S. Food and Drug Administration (FDA) of all testosterone gels, patches, creams, and injections prescribed to treat hypogonadism, which is low testosterone levels in men due to a medical condition and not due to the aging process. After receiving expert input from its advisory committee, and reviewing studies that reported an increased risk of heart attack, stroke or death associated with testosterone use, the FDA concluded that there is a possible cardiovascular risk associated with testosterone use.
[fda.gov/Drugs/DrugSafety/ucm436259.htm, FDA]

In March 2015, the FDA ordered manufacturers of all FDA-approved prescription testosterone products to add information on their labeling about the possible increased risk of heart attacks and strokes in men who use testosterone medications. The FDA also advised health care professionals to only prescribe testosterone treatment therapy for men with low testosterone levels caused by certain medical conditions and confirmed by lab tests.
[fda.gov/Drugs/DrugSafety/ucm436259.htm, FDA]

Court records indicate that testosterone claims are being prepared for trial that only involve AndroGel, the blockbuster low testosterone treatment gel manufactured and marketed by AbbVie and Abbott Laboratories. The bellwether trials expected to begin in October involve the AndroGel cases because the vast majority of the testosterone lawsuits pending in the MDL are filed against AbbVie and Abbott Laboratories. In November, 32 AndroGel lawsuits were submitted as potential cases for bellwether trials, and of that number six will be selected for bellwether trials.

In addition to AbbVie and Abbott Laboratories, other testosterone manufacturers named as defendants in the MDL are:

    • Actavis, Inc. and Watson Pharmaceuticals, which makes AndroDerm
    • Auxilium Pharmaceuticals, Inc., which makes Testim
    • Eli Lilly and Company and Lilly USA LLC, makers of Axiron
    • Endo Pharmaceuticals Inc., which makes Delatestryl and Fortesta
    • Pfizer Inc. and its subsidiary, Pharmacia & Upjohn Co.which makes and markets Depo-Testosterone

(In re: Testosterone Replacement Therapy Product Liability Litigation –
MDL No. 2545)

About Wright & Schulte LLC And Filing A Low Testosterone Drug Lawsuit

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free low testosterone lawsuit case evaluations are available through www.yourlegalhelp.com or by calling1-800-399-0795.

Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377